Severe Hypertryglyceridemia clinical trials

Explore recruiting severe hypertryglyceridemia clinical trials.

Also recruiting in Europe

Severe Hypertryglyceridemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ISIS 678354-CS6 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients with Severe Hypertriglyceridemia

France, Italy, Hungary, Belgium, Poland, Slovakia +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Severe Hypertryglyceridemia trials by city

Severe Hypertryglyceridemia in Toronto Severe Hypertryglyceridemia in Vancouver Severe Hypertryglyceridemia in Montreal Severe Hypertryglyceridemia in Calgary Severe Hypertryglyceridemia in Edmonton Severe Hypertryglyceridemia in Ottawa Severe Hypertryglyceridemia in Winnipeg Severe Hypertryglyceridemia in Quebec City Severe Hypertryglyceridemia in Hamilton Severe Hypertryglyceridemia in Kitchener Severe Hypertryglyceridemia in London Severe Hypertryglyceridemia in Halifax Severe Hypertryglyceridemia in New York Severe Hypertryglyceridemia in Los Angeles Severe Hypertryglyceridemia in Chicago Severe Hypertryglyceridemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease